3-MeO-PCMo, or 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine, is classified as an arylcyclohexylamine drug.3-MEO-PCMO,3-meo-pce roa, arylcyclohexylamines, mxpr wiki, mxe legality
Ayrlcyclohexylamine drugs are named for their structures which include a cyclohexane ring bound to an aromatic ring along with an amine group at the same location.
The aryl substituent of 3-MeO-PCMo is a phenyl ring with a methoxy (CH3-O-) substituent at R3, which is bound to a six-membered cyclohexyl ring.
Bound at the same location on the cyclohexyl ring R1 is an amine group which is incorporated into a morpholine ring as R4.
Morpholine is a six-membered heterocyclic ring with an oxygen subsitutent at R1. 3-MeO-PCMo is a morpholine analogue to 3-MeO-PCP, which lacks an oxygen moiety in its six-membered amine ring (a piperidine ring instead of a morpholine ring).
Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based on its structure and subjective effect similarities to other arylcyclohexylamine dissociatives such as 3-MeO-PCP, PCP and MXE.3-MEO-PCMO,3-meo-pce roa ,arylcyclohexylamines, mxpr wiki, mxe legality
With this in mind, 3-Meo-PCMo is thought to act as an NMDA receptor antagonist. NMDA receptors allow for electrical signals to pass between neurons in the brain and spinal column; for the signals to pass, the receptor must be open.6-MAPB
Dissociatives close the NMDA receptors by blocking them. This disconnection of neurons leads to loss of feeling, difficulty moving, and eventually this substance’s equivalent of the. 3-Fluoromethcathinone
|Chemical and physical data|
|3D model (JSmol)|